Related Experiment Video
Updated: Jan 27, 2026

10:37
Toeprinting Analysis of Translation Initiation Complex Formation on Mammalian mRNAs
Published on: May 10, 2018
13.1K
Repeat-associated non-AUG (RAN) translation: insights from pathology.
Monica Banez-Coronel1,2, Laura P W Ranum3,4,5,6,7
1Center for NeuroGenetics, University of Florida, Gainesville, FL, 32610, USA.
Summary
Repeat-associated non-AUG (RAN) translation causes nine neurological diseases. This review explores the pathology, molecular mechanisms, and in vivo models of RAN protein accumulation in these disorders.
Area of Science:
- Neurology
- Molecular Biology
- Genetics
Background:
- Microsatellite repeat expansions are linked to over 40 neurological diseases.
- Repeat-associated non-AUG (RAN) translation, discovered in 2011, is implicated in nine of these expansion disorders.
- RAN proteins can be translated from sense and antisense transcripts of repeat expansions.
Purpose of the Study:
- To review the pathological and molecular aspects of RAN protein accumulation in RAN-positive diseases.
- To correlate disease pathology with existing in vivo models.
- To identify common features among newly discovered RAN proteins.
Main Methods:
- Literature review of pathological and molecular aspects of RAN-positive diseases.
- Analysis of in vivo models for correlation with disease pathology.
- Comparative analysis of newly discovered RAN proteins.
Main Results:
- RAN proteins accumulate in affected brain regions in certain diseases.
- Specific pathological and molecular features are associated with RAN protein accumulation for each disorder.
- In vivo models show varying correlations with disease pathology.
Conclusions:
- RAN protein accumulation is a key pathological feature in nine identified expansion disorders.
- Understanding RAN protein mechanisms and in vivo models is crucial for disease research.
- Commonalities among RAN proteins offer insights into shared pathogenic pathways.
Related Concept Videos
Translation
156.1K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
156.1K
Translation
17.7K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
17.7K
Initiation of Translation
38.5K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
38.5K
Termination of Translation
27.5K
The large ribosomal subunit has several important structures essential to translation. These include the peptidyl transferase center (PTC) - which is the site where the peptide bond is formed - and a large, internal, water-filled tube through which the nascent polypeptide moves. This latter structure is called the Peptide Exit Tunnel, and it begins at the PTC and spans the body of the large ribosomal subunit. During translation, as the nascent polypeptide chain is synthesized, it passes through...
27.5K
Termination of Translation
6.7K
6.7K
Improving Translational Accuracy
14.1K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
14.1K

